Search
Searching Content indexed under Food and Drugs Law by Mishcon de Reya ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Advocate General Issues SPC Opinion In Teva V Gilead
On 25 April, Advocate General Wathelet issued his opinion on the interpretation of Article 3(a) SPC Regulation in the referral from the UK Patents Court in Teva & ors v Gilead ...
European Union
18 Jul 2018
2
Pfizer And Flynn Win Appeal Against Abuse Of Dominance Decision
The Competition Appeal Tribunal (CAT) has upheld appeals by Pfizer Limited and Flynn Pharma Limited in relation to significant fines imposed by the Competition and Markets Authority (CMA) ...
UK
18 Jul 2018
3
A High For Cannabidiol
There has been a huge amount of press interest very recently in medical cannabis, its effects, and whether it should be legalised.
UK
18 Jul 2018
4
The Potential Implications Of A Brexit Customs Union On Pharma And Biotech Industries
This would represent a ‘soft Brexit', and would also mean the UK would not be free to strike its own trade deals with non-EU countries.
UK
2 Mar 2018
5
Using Private Prosecutions To Tackle Counterfeit Drugs
As rights holders, the protection of your brand and IP are of paramount importance.
UK
27 Nov 2017
6
Infliximab: Battle Of The Biosimilars
On 23 May, the CMA issued a statement of objections, which is a provisional finding that Merck Sharp & Dohme Limited (MSD) has breached UK competition law by abusing its dominant position.
UK
27 Nov 2017
Links to Result pages
 
1